Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Knowing what data is needed for financial analysis is crucial for accurate assessments. Gather the essential information to make informed financial decisions.
26,603 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Greece rolls out a four-satellite network that detects fires as small as four meters wide, aiming to cut wildfire los...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Block pivots on AI, slashing 40% of jobs as it refocuses on crypto tools and fintech services. This morning minute lo...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
A Workday insider recently sold a sizable block of shares. This article breaks down what that signals for investors, ...
A single, high-stakes scenario could ripple through the U.S. power grid, telecom networks, and financial systems. Thi...
In this artificial intelligence stocks march moment, savvy investors seek clarity on durable bets. This guide breaks ...
Anthropic's study identifies which roles are most exposed to AI, warning of wage pressure and hiring shifts as automa...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
A director sold 20,000 shares of First Merchants Corp in a move totaling about $835k. This article explains why insid...
Prediction markets are moving into the mainstream. This piece examines whether Polymarket likely 2026? could bring an...